Raptor Pharmaceutical

Raptor Pharmaceutical Corp. (NASDAQ: RPTP) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover...

Raptor Pharmaceutical Corp. (NASDAQ: RPTP), a biopharmaceutical company with a focus on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, announced Thursday evening that it has entered into a definitive agreement with Tripex...